What Tissue Microarray Immunohistochemistry Scoring Is
Tissue microarray (TMA) immunohistochemistry (IHC) scoring is a technique used to quantify protein expression levels in tissue samples. This method involves the creation of a TMA, where multiple small tissue cores are arranged on a single slide for efficient and cost-effective analysis.
The IHC process uses antibodies specific to target proteins, which bind to their respective antigens within the tissue sections. The bound antibodies are then detected using secondary reagents, often involving enzymes or fluorescent dyes, allowing for visualization under a microscope.
Why It Matters
TMA-IHC scoring is crucial in biomarker discovery as it allows researchers to assess protein expression levels across multiple tissue samples simultaneously. This technique can help identify proteins that are associated with disease states, prognosis, or therapeutic response.
By quantifying the intensity and distribution of protein expression, TMA-IHC scoring provides valuable information for developing diagnostic tools, understanding disease mechanisms, and guiding personalized medicine approaches.
How It Works
The process begins with selecting relevant tissue samples from patients or animal models. These tissues are then microdissected to obtain small cores of approximately 0.6 mm in diameter, which are embedded into a TMA block. The block is sliced into sections for staining.
Following the IHC procedure, the slides are examined under a microscope by pathologists who score the stained areas based on predefined criteria such as intensity and extent of staining.
Real-World Applications
TMA-IHC scoring has been widely used in oncology to identify prognostic and predictive biomarkers. For example, it can help determine the likelihood of recurrence or response to specific therapies based on protein expression levels.
In addition, this technique is valuable for studying other diseases such as Alzheimer's disease, where changes in the expression of certain proteins are associated with disease progression.
Frequently asked questions
What is a tissue microarray?
A tissue microarray (TMA) is a method for arranging multiple small tissue cores from different patients or samples on a single slide, allowing for simultaneous analysis of these tissues.
Why is IHC scoring important in biomarker discovery?
IHC scoring helps identify proteins that are associated with specific disease states, prognosis, and therapeutic response, which can be used to develop diagnostic tools and personalized medicine strategies.
How does TMA-IHC scoring differ from traditional IHC techniques?
TMA-IHC allows for the analysis of multiple tissue samples simultaneously on a single slide, making it more efficient compared to traditional IHC methods where each sample is analyzed individually.
What are some common applications of TMA-IHC scoring?
Common applications include identifying prognostic and predictive biomarkers in oncology, studying disease progression, and developing diagnostic tools for various diseases such as Alzheimer's.
Try it live
Everything above runs in your browser — open Tissue Microarray Immunohistochemistry Scoring and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.
▶ Open Tissue Microarray Immunohistochemistry Scoring simulation